[177Lu]Lu-XT117

DRUG2 trials

Sponsors

Xinlu Wang, Ruimin Wang

Conditions

Advanced Solid Tumor

Phase 1

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

RecruitingNCT06197139

Xinlu WangAdvanced Solid Tumor

Start: 2024-01-31End: 2026-12-31Target: 20Updated: 2024-01-09

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

RecruitingNCT06211647

Ruimin WangAdvanced Solid Tumor

Start: 2024-01-31End: 2026-12-31Target: 20Updated: 2024-01-18

Related Papers

Safety and efficacy of <sup>177</sup>Lu-FAPI-XT radioligand therapy in patients with advanced sarcoma and other cancer entities: first-in-human, dose-escalation study.

2025-10-15